NDC 0169-0081
Prandin
Repaglinide
Prandin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Repaglinide.
| Product ID | 0169-0081_814078bb-8c13-a996-e053-2991aa0ab042 |
| NDC | 0169-0081 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Prandin |
| Generic Name | Repaglinide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2000-01-03 |
| Marketing End Date | 2020-10-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020741 |
| Labeler Name | Novo Nordisk |
| Substance Name | REPAGLINIDE |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| NDC Exclude Flag | N |
Packaging
NDC 0169-0081-82
500 TABLET in 1 BOTTLE, PLASTIC (0169-0081-82)
| Marketing Start Date | 2000-01-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0169-0081-81 [00169008181]
Prandin TABLET
| Marketing Category | NDA |
| Application Number | NDA020741 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-01-03 |
| Marketing End Date | 2020-10-31 |
NDC 0169-0081-83 [00169008183]
Prandin TABLET
| Marketing Category | NDA |
| Application Number | NDA020741 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-01-03 |
| Marketing End Date | 2013-04-16 |
NDC 0169-0081-82 [00169008182]
Prandin TABLET
| Marketing Category | NDA |
| Application Number | NDA020741 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2000-01-03 |
| Marketing End Date | 2020-10-31 |
NDC 0169-0081-80 [00169008180]
Prandin TABLET
| Marketing Category | NDA |
| Application Number | NDA020741 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2000-01-03 |
| Marketing End Date | 2020-10-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| REPAGLINIDE | .5 mg/1 |
OpenFDA Data
| SPL SET ID: | 4c1c212f-71a5-4dd3-81b2-cd9e2148774c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Glinide [EPC]
- Potassium Channel Antagonists [MoA]
- Glinide [EPC]
- Potassium Channel Antagonists [MoA]
NDC Crossover Matching brand name "Prandin" or generic name "Repaglinide"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0169-0081 | Prandin | repaglinide |
| 0169-0082 | Prandin | repaglinide |
| 0169-0084 | Prandin | repaglinide |
| 68151-3566 | Prandin | Prandin |
| 68151-3565 | Prandin | Prandin |
| 60846-882 | Prandin | Prandin |
| 60846-884 | Prandin | Prandin |
| 0378-3122 | Repaglinide | repaglinide |
| 0378-3123 | Repaglinide | repaglinide |
| 0574-0240 | Repaglinide | REPAGLINIDE |
| 0574-0241 | Repaglinide | REPAGLINIDE |
| 0574-0242 | Repaglinide | REPAGLINIDE |
| 51079-539 | Repaglinide | repaglinide |
| 51991-853 | REPAGLINIDE | REPAGLINIDE |
| 51991-854 | REPAGLINIDE | REPAGLINIDE |
| 51991-855 | REPAGLINIDE | REPAGLINIDE |
| 57237-157 | Repaglinide | Repaglinide |
| 57237-158 | Repaglinide | Repaglinide |
| 57237-159 | Repaglinide | Repaglinide |
| 57664-745 | Repaglinide | Repaglinide |
| 57664-747 | Repaglinide | Repaglinide |
| 60429-484 | REPAGLINIDE | REPAGLINIDE |
| 60429-485 | REPAGLINIDE | REPAGLINIDE |
| 60429-486 | REPAGLINIDE | REPAGLINIDE |
Trademark Results [Prandin]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PRANDIN 75272035 2330531 Live/Registered |
NOVO NORDISK A/S 1997-04-09 |
 PRANDIN 72412854 0954329 Dead/Expired |
UPJOHN COMPANY, THE 1972-01-17 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.